ASP Isotopes shares surge 13.7% after-hours as CEO Paul Mann returns from medical leave, boosting confidence in HALEU project.

ASP Isotopes Inc. surged 13.7% in after-hours trading following Cantor Fitzgerald’s initiation of coverage with an "Overweight" rating and a $13 price target, signaling strong institutional confidence in the company’s strategic advancements. The analyst cited key catalysts including CEO Paul Mann’s return in January, progress on the HALEU project, and the $64.3M private offering for laser enrichment technology. These developments, coupled with Quantum Leap Energy’s IPO plans, underscored the firm’s bullish outlook. While the CEO’s return and UK nuclear project were previously highlighted as confidence boosters, the immediate price reaction aligned with Cantor Fitzgerald’s formal endorsement, which reinforced the stock’s upward momentum ahead of broader market open.